Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib.
Shun KanekoKaoru TsuchiyaYutaka YasuiKento InadaSakura KirinoKoji YamashitaLeona OsawaYuka HayakawaShuhei SekiguchiMayu HiguchiKenta TakauraChiaki MaeyashikiNobuharu TamakiTakaya TakeguchiYuko TakeguchiHiroyuki NakanishiJun ItakuraYuka TakahashiYoshiro HimenoMasayuki KurosakiNamiki IzumiPublished in: JGH open : an open access journal of gastroenterology and hepatology (2020)
RECIST 1.1 was useful even as early therapeutic evaluation for HCC patients treated with LEN. Understanding the characteristics of radiological response over time may contribute to improving the prognosis of patients with HCC.
Keyphrases